Evidence map›Paper›PMID 38589742›Full record

ArticleEuropean radiology experimental2024

Public data homogenization for AI model development in breast cancer.

Vassilis Kilintzis, Varvara Kalokyri, Haridimos Kondylakis, Smriti Joshi, Katerina Nikiforaki, Oliver Díaz, Karim Lekadir, Manolis Tsiknakis, Kostas Marias

Abstract read
In one paragraph

Article in European radiology experimental, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vassilis KilintzisInstitute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece. billyk@ics.forth.gr.ORCID http://orcid.org/0000-0002-9783-6757
Varvara KalokyriInstitute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece.
Haridimos KondylakisInstitute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece.
Smriti JoshiBarcelona Artificial Intelligence in Medicine Lab, Facultat de Matemàtiques I Informàtica, Universitat de Barcelona, Barcelona, Spain.
Katerina NikiforakiInstitute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece.
Oliver DíazBarcelona Artificial Intelligence in Medicine Lab, Facultat de Matemàtiques I Informàtica, Universitat de Barcelona, Barcelona, Spain.
Karim LekadirBarcelona Artificial Intelligence in Medicine Lab, Facultat de Matemàtiques I Informàtica, Universitat de Barcelona, Barcelona, Spain.
Manolis TsiknakisInstitute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece.
Kostas MariasInstitute of Computer Science (ICS), Foundation for Research and Technology - Hellas (FORTH), Heraklion, Crete, Greece.

Funding

HORIZON EUROPE Framework Programme 101057699
6 · The paper itself

Abstract

backgroundDeveloping trustworthy artificial intelligence (AI) models for clinical applications requires access to clinical and imaging data cohorts. Reusing of publicly available datasets has the potential to fill this gap. Specifically in the domain of breast cancer, a large archive of publicly accessible medical images along with the corresponding clinical data is available at The Cancer Imaging Archive (TCIA). However, existing datasets cannot be directly used as they are heterogeneous and cannot be effectively filtered for selecting specific image types required to develop AI models. This work focuses on the development of a homogenized dataset in the domain of breast cancer including clinical and imaging data.

methodsFive datasets were acquired from the TCIA and were harmonized. For the clinical data harmonization, a common data model was developed and a repeatable, documented "extract-transform-load" process was defined and executed for their homogenization. Further, Digital Imaging and COmmunications in Medicine (DICOM) information was extracted from magnetic resonance imaging (MRI) data and made accessible and searchable.

resultsThe resulting harmonized dataset includes information about 2,035 subjects with breast cancer. Further, a platform named RV-Cherry-Picker enables search over both the clinical and diagnostic imaging datasets, providing unified access, facilitating the downloading of all study imaging that correspond to specific series' characteristics (e.g., dynamic contrast-enhanced series), and reducing the burden of acquiring the appropriate set of images for the respective AI model scenario.

conclusionsRV-Cherry-Picker provides access to the largest, publicly available, homogenized, imaging/clinical dataset for breast cancer to develop AI models on top. RELEVANCE STATEMENT: We present a solution for creating merged public datasets supporting AI model development, using as an example the breast cancer domain and magnetic resonance imaging images. KEY POINTS: • The proposed platform allows unified access to the largest, homogenized public imaging dataset for breast cancer. • A methodology for the semantically enriched homogenization of public clinical data is presented. • The platform is able to make a detailed selection of breast MRI data for the development of AI models.

Indexed as

Breast NeoplasmsArtificial IntelligenceBreastFemaleHumansArtificial intelligence, Breast neoplasms, Magnetic resonance imaging, Public datasets, Software

Identifiers

PMID38589742
PMCPMC11001841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.